Medrad, Inc.
Since 1964, MEDRAD has developed products that clinicians worldwide rely on to provide outstanding performance every time they're used. Performance that helps physicians diagnose patients more accurately and, ultimately, deliver quality patient care. You will find that same level of performance, along with the high level of customer support you've come to expect from MEDRAD, with each product and service that carries our name. Our customers have told us what they value most about MEDRAD - high-performing products and the support of people who make a difference in the lives of patients around the world. This promise of unequaled reliability and trust in our products, people, and services can be summed up in a simple, yet powerful phrase - Performance. For life.
RELATED CONTENT
August 23, 2010 — The Intego positron emission tomography (PET) infusion system is now listed with Novation LLC, one of the largest healthcare supply contracting companies in the United States. Novation is the first supply contracting company to list Intego and the first to list any automated infusion system for molecular imaging. Novation serves the purchasing needs of nearly 25,000 healthcar
August 30, 2010 
August 4, 2010 - A disposable, single-use rectal balloon device immobilizes the rectal wall and adjacent structures of the anatomy and enables repeatable positioning throughout the course of radiation therapy treatment.
August 03, 2010
July 7, 2010 – The U.S. Food and Drug Administration (FDA) has granted Medrad Inc. clearance to market the Medrad Intego positron emission tomography (PET) infusion system for sodium fluoride (F18-NaF) administration in PET imaging. F18-NaF PET is most frequently used in oncology to find and assess bone metastases.
July 07, 2010 
May 20, 2010 – A new partnership enables data communication between Medrad's Intego positron emission tomography (PET) infusion system and Pinestar Technology's Nuclear Medicine Information System (NMIS). The companies are closing the information gap between infusion systems and the information systems, adding to the workflow benefits of automated fludeoxyglucose (FDG) infusion.
May 19, 2010 Certegra’s Connect.PACS™ application makes available new and more complete information to better inform decision making. The application instantly integrates each patient’s CT contrast injection record with the associated clinical image sets stored in PACS. Connect.PACS automates recordkeeping, facilitates Joint Commission compliance and reduces manual records discrepancies.
September 23, 2009 P3T products automate protocol personalization and consistently enable improved contrast enhancement for higher quality images for CT angiography and abdominal studies. P3T Cardiac enhances CT angiography of cardiac structures, coronary arteries, chambers of the heart, thoracic and abdominal aorta, and pulmonary vasculature for pulmonary embolism (PE) studies.
September 23, 2009 
August 13, 2009 - MEDRAD has introduced an eight-piece microbore disposables set for the Continuum MR Infusion System, which it is featuring at the AHRA meeting.
The disposables set reduces the priming volume of pharmaceuticals used and, as a result, reduces procedure cost.
August 13, 2009 
June 5, 2009 – MEDRAD Inc. has launched Manage.Report, an informatics application that enables healthcare professionals to access clinical and administrative information associated with radiology patients’ contrast injections from nearly anywhere.
June 04, 2009 
The MEDRAD Informatics Solution platform uses a service-oriented architecture that automates capture of power injection records and provides authenticated users access to current and archived injection reports. Users meet their information needs via Web browser from within the healthcare enterprise.
May 04, 2009 
March 20, 2009 – MEDRAD Inc. Multi Vendor Service has launched TotalRepair, reportedly the first and only guaranteed repair solution on select ultrasound probes.
Enabled by 100 percent repair capabilities, TotalRepair aims to allow healthcare facilities to spend less on costly exchanges and replacements by maximizing the use of probe repair.
March 20, 2009